• Home
  • Pegylated liposomal doxorubicin and cyclophosphamide as first-line therapy for patients with metastatic or recurrent breast cancer.

Pegylated liposomal doxorubicin and cyclophosphamide as first-line therapy for patients with metastatic or recurrent breast cancer.

Author List
Overmoyer B, Silverman P, Holder LW, Tripathy D, Henderson IC
Publication
Clinical breast cancer
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1442993
Publication Year
2005
PubMed ID
16001993
Publication Title
Overmoyer B, Silverman P, Holder LW, Tripathy D, Henderson IC. Pegylated liposomal doxorubicin and cyclophosphamide as first-line therapy for patients with metastatic or recurrent breast cancer. Clin Breast Cancer. 2005 Jun; 6(2):150-7.